Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-26-024523
Filing Date
2026-07-27
Accepted
2026-07-27 16:34:57
Documents
51
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20260630_10q.htm   iXBRL 10-Q 678784
2 EXHIBIT 31.1 ex_991962.htm EX-31.1 12345
3 EXHIBIT 31.2 ex_991963.htm EX-31.2 12427
4 EXHIBIT 32.1 ex_991964.htm EX-32.1 4646
5 EXHIBIT 32.2 ex_991965.htm EX-32.2 4666
  Complete submission text file 0001437749-26-024523.txt   3431870

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA govx-20260630.xsd EX-101.SCH 36067
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20260630_def.xml EX-101.DEF 209927
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20260630_lab.xml EX-101.LAB 209384
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20260630_pre.xml EX-101.PRE 234739
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE govx-20260630_cal.xml EX-101.CAL 27893
55 EXTRACTED XBRL INSTANCE DOCUMENT govx20260630_10q_htm.xml XML 400420
Mailing Address 1955 LAKE PARK DRIVE SUITE 300 SMYRNA GA
Business Address 1955 LAKE PARK DRIVE SUITE 300 SMYRNA GA 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39563 | Film No.: 261206254
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)